SEC Filing Summary: Xenomics, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Xenomics, Inc., a Florida corporation, on October 26, 2004, covering events that occurred on October 25, 2004. The filing addresses corporate governance changes at the registrant's principal executive offices located in New York, New York.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance disclosures and contains no financial performance data.
Material Changes
The primary material change reported is the alteration of the Board of Directors composition:
- Resignation: Gary S. Jacob resigned as a director of Xenomics, Inc. effective October 25, 2004.
- Elections: Immediately following the resignation, the board elected V. Randy White and Thomas Adams to serve as directors until the next annual meeting of stockholders or until their successors are duly elected and qualified.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document focuses solely on the departure and election of directors.
Key Facts for Investor Verification
- Verify the current composition of the Xenomics, Inc. Board of Directors following the October 25, 2004 meeting.
- Confirm the tenure and qualifications of the newly elected directors, V. Randy White and Thomas Adams.
- Note that the registrant's name in the filing header is Xenomics, Inc., despite the request metadata referencing Cardiff Oncology, Inc.